Delta Journal of Ophthalmology

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 19  |  Issue : 1  |  Page : 14--18

Argon laser treatment for symptomatic inferior conjunctivochalasis refractory to medical therapy


Mona M Aly 
 Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Correspondence Address:
Mona M Aly
Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Nasr City 11754, Cairo
Egypt

Purpose The aim of this study was to present argon laser procedure as a treatment option for symptomatic inferior conjunctivochalasis (CCh) refractory to medical therapy and to evaluate its efficacy. Patients and methods A prospective interventional study was conducted to evaluate the clinical results after argon laser photocoagulation for symptomatic inferior CCh using a slit-lamp-mounted argon laser under topical anesthesia. Twenty eyes with CCh refractory to medical treatment were enrolled in the study. Results The symptoms significantly improved in all patients, and the conjunctival laxity disappeared in eight (40%) of 20 eyes and improved in the remaining 12 (60%) eyes after the treatment of CCh with argon laser. Conclusion Argon laser photocoagulation of the conjunctiva can successfully treat CCh with symptomatic attenuation.


How to cite this article:
Aly MM. Argon laser treatment for symptomatic inferior conjunctivochalasis refractory to medical therapy.Delta J Ophthalmol 2018;19:14-18


How to cite this URL:
Aly MM. Argon laser treatment for symptomatic inferior conjunctivochalasis refractory to medical therapy. Delta J Ophthalmol [serial online] 2018 [cited 2018 Aug 17 ];19:14-18
Available from: http://www.djo.eg.net/article.asp?issn=1110-9173;year=2018;volume=19;issue=1;spage=14;epage=18;aulast=Aly;type=0